Literature DB >> 19465612

Observation unit admission as an alternative to inpatient admission for trauma activation patients.

T E Madsen1, J R Bledsoe, P J Bossart.   

Abstract

BACKGROUND: At this 35 000 visits/year emergency department (ED) at a level one trauma centre, a trauma protocol was implemented for the ED observation unit. Data on all trauma observation unit admissions were then collected to evaluate for safety, efficiency and admission rates.
METHODS: A retrospective chart review was performed of all trauma patients in the observation unit during a 14-month period. Exclusion criteria for observation unit admission included: abnormal vital signs, positive focussed abdominal sonography for trauma examination, abnormal ECG, abnormal chest radiograph, abnormal head computed tomography, Glasgow coma score less than 14, or multisystem trauma.
RESULTS: 364 trauma patients were admitted to the observation unit. 84.6% were trauma II activations and 3.8% were trauma I activations. There were no deaths, intubations, loss of vital signs or other adverse events. The average length of stay was 12 h 46 minutes and 11.5% of patients were admitted to an inpatient unit. At 30-day follow-up, there were no significant missed injuries.
CONCLUSION: The observation unit is a safe alternative to inpatient admission for the evaluation of the minimally injured trauma activation patient.

Entities:  

Mesh:

Year:  2009        PMID: 19465612     DOI: 10.1136/emj.2008.064626

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  2 in total

Review 1.  Emergency department observation units and the older patient.

Authors:  Mark G Moseley; Miles P Hawley; Jeffrey M Caterino
Journal:  Clin Geriatr Med       Date:  2013-02       Impact factor: 3.076

2.  Design and application of an information system for the emergency observation room in a Chinese hospital.

Authors:  Lan Wei; Shuo Dong; Xiaolu Fei
Journal:  J Med Syst       Date:  2013-01-16       Impact factor: 4.460

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.